Emotion Regulation Group Therapy for Bipolar Disorder
This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Thilo Deckersbach, Massachusetts General Hospital
First received: September 7, 2010
Last updated: August 12, 2013
Last verified: August 2013
Psychoeducation has been the only group treatment developed for bipolar disorder thus far. Deficits in emotion regulation, a core impairment among patients with bipolar disorder, are not directly addressed in this treatment. The objective of this study is to develop a group treatment for bipolar disorder that focuses on emotion regulation strategies (Enhancing Emotion Regulation; EER). This study will examine the efficacy of this treatment using an open trial design. It is hypothesized that patients who receive EER will show a reduction in mood symptoms and improvement in well-being. Reductions in emotion regulation difficulties will predict improvements.
Bipolar I Disorder
Behavioral: Enhancing Emotion Regulation
||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
||Emotion Regulation Group Therapy for Bipolar Disorder
Primary Outcome Measures:
- Hamilton Depression Rating Scale [ Time Frame: Up to 24 weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||December 2013 (Final data collection date for primary outcome measure)
Experimental: Enchancing Emotion Regulation
12 week group 3 week modules: 1) Mindfulness 2) Emotion Regulation 3) Distress Tolerance
Behavioral: Enhancing Emotion Regulation
12 week of group therapy 3 modules: 1) mindfulness, 2) emotion regulation, 3)distress tolerance
|Ages Eligible for Study:
||18 Years to 65 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Diagnosis of bipolar I disorder.
- Able to provide written informed consent.
- Men or women aged 18-65.
- Able to read and understand English.
- Psychiatrist prescribing mood-stabilizing medication.
- Participates in bimonthly individual psychotherapy
- Subjects with suicidal ideation where outpatient treatment is determined unsafe by the study clinician. These patients will be immediately referred to appropriate clinical treatment.
- History of seizure disorder, brain injury, any history of known neurological disease (multiple sclerosis, degenerative disease such as ALS, Parkinson disease and any movement disorders, etc).
- History or current diagnosis of the following Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) psychiatric illness: organic mental disorder, schizophrenia, schizoaffective disorder, delusional disorder, psychotic disorders not otherwise specified, major depressive disorder, patients with mood congruent or mood incongruent psychotic features, patients with substance dependence disorders, including alcohol, active within the last 12 months.
- Patients who currently meet criteria for a major depressive episode, a manic episode, or a mixed episode. Excluded participants may remain on a waiting list to partake in a future group dependent on mood stabilization.
- Patients who have had electroconvulsive therapy (ECT) within the 6 months preceding enrollment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01207505
|Bipolar Clinic and Research Program
|Boston, Massachusetts, United States, 02114 |
Massachusetts General Hospital
||Thilo Deckersbach, Ph.D.
||Bipolar Clinic and Research Program
No publications provided
||Thilo Deckersbach, Director of Psychology, Bipolar Clinic and Research Program Associate Professor of Psychology, Harvard Medical School, Massachusetts General Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||September 7, 2010
||August 12, 2013
||United States: Institutional Review Board
Keywords provided by Massachusetts General Hospital:
dialectical behavior therapy
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on August 20, 2014
Affective Disorders, Psychotic